According to Zhitong Finance App News, Microchip Biotech (688321.SH) issued an announcement. On November 14, 2026, in accordance with the notice issued by the National Health Insurance Administration and the Ministry of Human Resources and Social Security to issue the “National Medical Insurance Catalogue” (“National Health Insurance Catalogue”) and the “Commercial Health Insurance Innovative Drug Catalogue” (2026), the company's product Siglita sodium tablets (bisulopine®) successfully renewed the “National Health Insurance Catalogue”.

Zhitongcaijing · 1d ago
According to Zhitong Finance App News, Microchip Biotech (688321.SH) issued an announcement. On November 14, 2026, in accordance with the notice issued by the National Health Insurance Administration and the Ministry of Human Resources and Social Security to issue the “National Medical Insurance Catalogue” (“National Health Insurance Catalogue”) and the “Commercial Health Insurance Innovative Drug Catalogue” (2026), the company's product Siglita sodium tablets (bisulopine®) successfully renewed the “National Health Insurance Catalogue”.